Foreign Aid Groups Continue Their Fight Against the Trump Administration — In Court
*This article originally appeared on NOTUS.
Organizations affected by an appeals court’s decision are asking for a do-over, concerned that the separation of powers is at stake.
A D.C. court panel said foreign aid groups have no standing to sue President Donald Trump and his administration for refusing to spend funds allocated by Congress. But for the affected foreign aid organizations, the legal fight isn’t over.
Mitchell Warren, executive director of the AIDS Vaccine Advocacy Coalition — one of the leading groups attempting to sue the administration — told NOTUS that groups are petitioning for a rehearing in front of the full appeals court.
“We believe when the full court reviews this, they will find on our side that we do have standing,” Warren said. “And that indeed the president and the administration are wrong and that they are not allowed to ignore congressional power of the purse, which is what the Constitution itself says.”
The three-judge federal appeals court panel ruled Wednesday that the plaintiffs don’t have standing to sue the federal government for impounding funds. But even if the case gets another look, the decision could still stand against the foreign aid groups.
That would be a significant blow for humanitarian organizations that have already been struggling under the administration’s funding freeze and the dismantling of the U.S. Agency for International Development.
“There is going to be a tremendous loss of money appropriated by Congress that could have been used to get food to starving children, open up schools and give girls opportunities to read, provide vaccines, provide shelter and water to people fleeing conflicts and crises around the world,” said Lisa Bos, vice president for policy and government relations at InterAction, a network of humanitarian nonprofits.
Elisha Dunn-Georgiou, president and CEO of the Global Health Council, another of the lead plaintiffs, told NOTUS that the impoundment of congressionally appropriated funding, if nothing changes, will affect the whole global public health infrastructure and harm the member organizations she works with.
“It’s really a tragic decision in so many ways, and tragic for the, you know, ceding congressional power to the executive,” she said. “But then in a much broader, more human sense, you’re talking about people who are going to be sick and dying.”
Read the full article here.